Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Reu

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 10, 2012
Activation of cannabinoid receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanismsThomas Michler, Martin Storr, Johannes Kramer, et al.
Respiration; International Review of Thoracic Diseases|December 1, 2017
NSCLC Patients Harbouring Rare or Complex EGFR Mutations Are More Often Smokers and Might Not Benefit from First-Line Tyrosine Kinase Inhibitor TherapyDiego Kauffmann-Guerrero, Rudolf Maria Huber, Simone Reu, et al.
Pediatric Pulmonology|October 14, 2021
Pulmonary alveolar proteinosis due to heterozygous mutation in OAS1: Whole lung lavages for long-term bridging to hematopoietic stem cell transplantationElias Seidl, Dirk Schramm, Carola Schön, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Preselection based on clinical characteristics in German non-small-cell lung cancer patients screened for EML4-ALK translocationAmanda Laura Helen Tufman, Martin Edelmann, Fernando Gamarra, et al.
Oncotargets and Therapy|November 11, 2017
Frequency and clinical relevance of EGFR mutations and EML4-ALK translocations in octogenarians with non-small cell lung cancerAmanda Tufman, Kathrin Kahnert, Thomas Duell, et al.
Oncology Research and Treatment|April 9, 2020
Response to Checkpoint Inhibition in Non-Small Cell Lung Cancer with Molecular Driver AlterationsDiego Kauffmann-Guerrero, Amanda Tufman, Kathrin Kahnert, et al.
Journal of Cancer Research and Clinical Oncology|July 15, 2014
ALK expression is absent in pancreatic ductal adenocarcinomaSteffen Ormanns, Gerald Assmann, Simone Reu, et al.
Frontiers in Immunology|June 5, 2023
Delayed and limited administration of the JAKinib tofacitinib mitigates chronic DSS-induced colitisRishav Seal, Lara S U Schwab, Cristina M Chiarolla, et al.
Cancer Research|July 24, 2020
Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small Cell Lung CarcinomaXiang Zheng, Andreas Weigert, Simone Reu, et al.
Surgery|March 31, 2015
Histomorphologic and molecular phenotypes predict gemcitabine response and overall survival in adenocarcinoma of the ampulla of VaterTobias S Schiergens, Simone Reu, Jens Neumann, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 10, 2012
Activation of cannabinoid receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanismsThomas Michler, Martin Storr, Johannes Kramer, et al.
Respiration; International Review of Thoracic Diseases|December 1, 2017
NSCLC Patients Harbouring Rare or Complex EGFR Mutations Are More Often Smokers and Might Not Benefit from First-Line Tyrosine Kinase Inhibitor TherapyDiego Kauffmann-Guerrero, Rudolf Maria Huber, Simone Reu, et al.
Pediatric Pulmonology|October 14, 2021
Pulmonary alveolar proteinosis due to heterozygous mutation in OAS1: Whole lung lavages for long-term bridging to hematopoietic stem cell transplantationElias Seidl, Dirk Schramm, Carola Schön, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Preselection based on clinical characteristics in German non-small-cell lung cancer patients screened for EML4-ALK translocationAmanda Laura Helen Tufman, Martin Edelmann, Fernando Gamarra, et al.
Oncotargets and Therapy|November 11, 2017
Frequency and clinical relevance of EGFR mutations and EML4-ALK translocations in octogenarians with non-small cell lung cancerAmanda Tufman, Kathrin Kahnert, Thomas Duell, et al.
Oncology Research and Treatment|April 9, 2020
Response to Checkpoint Inhibition in Non-Small Cell Lung Cancer with Molecular Driver AlterationsDiego Kauffmann-Guerrero, Amanda Tufman, Kathrin Kahnert, et al.
Journal of Cancer Research and Clinical Oncology|July 15, 2014
ALK expression is absent in pancreatic ductal adenocarcinomaSteffen Ormanns, Gerald Assmann, Simone Reu, et al.
Frontiers in Immunology|June 5, 2023
Delayed and limited administration of the JAKinib tofacitinib mitigates chronic DSS-induced colitisRishav Seal, Lara S U Schwab, Cristina M Chiarolla, et al.
Cancer Research|July 24, 2020
Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small Cell Lung CarcinomaXiang Zheng, Andreas Weigert, Simone Reu, et al.
Surgery|March 31, 2015
Histomorphologic and molecular phenotypes predict gemcitabine response and overall survival in adenocarcinoma of the ampulla of VaterTobias S Schiergens, Simone Reu, Jens Neumann, et al.
Pageof 7